The MEDCAN Fund 

What do we look for?

The Fund employs a strict investment process in order to maximise the ability to invest in the best companies whilst minimising the risk of losses.

1. The Fund's aim is to achieve a minimum target return of 3x.
2. When investing in companies with pre-clinical and/or phase 1 data, the Fund targets those that have significant value inflection points within the exit horizon.
3. In each deal we identify the “value add” the Oskare team brings to the target company.
4. For every deal, we ensure founders and the Fund are aligned (values, commercially, scientifically).
5. The Fund will invest in companies that we can syndicate with partners.
6. We listen to founders and their vision of the company. We decide if the "fit" with the Fund is right and if the team is well balanced in terms of skills and experience, as well as coachable.
7. The Fund does not invest in companies that are not ESG compatible and they must operate within the legal frameworks of their current or future jurisdictions (including the Fund jurisdiction).
8. Investments are to be made in companies whose products have strong barriers to entry and teams with strong execution capability.
9. All companies will be eligible for EIS and/or SEIS. Before an investment is made, the Investee Company must have obtained HMRC SEIS and/or EIS advance assurance.
10. The Fund does not invest in companies where we do not understand the technology or market.

To invest, you must be an eligible investor. To be an eligible investor, you must be qualifying as one or more of the following:

• You meet the FCA’s definition of a professional investor.
• You meet the FCA’s definition of a certified high net worth investor.
• You meet the FCA’s definition of a self-certified sophisticated investor.
• You meet the FCA’s definition of a self-certified restricted investor.
• You are a client of an FCA authorised firm that will provide advice on the suitability of the product in question.

Risk Warning

Important information for private investors – Reliance on the information provided here to engage in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested. Your attention is drawn to the risk section contained within the Information Memorandum. Investments are typically in unquoted shares in small companies, the value of which can be volatile and are often difficult to sell. Nothing on this website constitutes investment, tax, financial, legal, regulatory, or other advice by Sapphire Capital Partners LLP.

The value of an investment may go down as well as up, and you may not get back the full amount invested, and you may therefore lose some or all of your investment.

If you are unsure of the suitability of any investment for your circumstances, please contact your independent financial advisor or other professional advisor authorised under the Financial Services and Markets Act 2000 (FSMA) who specialises in advising on investments of this type. Tax reliefs depend on individual circumstances. There is no guarantee however that the tax reliefs (such as EIS reliefs, CGT reliefs or IHT relief) will be available on any investment made or that if it is initially available, it will not be subsequently withdrawn. Any references to tax laws or rates are based on current legislation, all of which are subject to change and are provided as a guide only. Prospective investors are advised to take their own investment and taxation advice and should consult their own professional advisors on the implications of investing.

Investments made in investee companies via funds managed by Sapphire Capital Partners LLP are not covered by the Financial Services Compensation Scheme (FSCS). For more details, please contact us or refer to their website: https://www.fscs.org.uk

Past performance is not a guide to future returns.